Literature DB >> 15006595

Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease.

Folkert W Asselbergs, Wanda F Reynolds, Jan W Cohen-Tervaert, Gillian A J Jessurun, René A Tio.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15006595     DOI： 10.1016/j.amjmed.2003.10.025

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  24 in total

1.  Role of VPO1, a newly identified heme-containing peroxidase, in ox-LDL induced endothelial cell apoptosis.

Authors:  Yong-Ping Bai; Chang-Ping Hu; Qiong Yuan; Jun Peng; Rui-Zheng Shi; Tian-Lun Yang; Ze-Hong Cao; Yuan-Jian Li; Guangjie Cheng; Guo-Gang Zhang
Journal:  Free Radic Biol Med       Date:  2011-07-19       Impact factor: 7.376

2.  Human myeloperoxidase (hMPO) is expressed in neurons in the substantia nigra in Parkinson's disease and in the hMPO-α-synuclein-A53T mouse model, correlating with increased nitration and aggregation of α-synuclein and exacerbation of motor impairment.

Authors:  Richard A Maki; Michael Holzer; Khatereh Motamedchaboki; Ernst Malle; Eliezer Masliah; Gunther Marsche; Wanda F Reynolds
Journal:  Free Radic Biol Med       Date:  2019-06-06       Impact factor: 7.376

3.  Risk prediction with serial myeloperoxidase monitoring in patients with acute chest pain.

Authors:  Stephen J Nicholls; W H Wilson Tang; Danielle Brennan; Marie-Luise Brennan; Shirley Mann; Steven E Nissen; Stanley L Hazen
Journal:  Clin Chem       Date:  2011-09-22       Impact factor: 8.327

Review 4.  Genetic markers of oxidative stress and coronary atherosclerosis.

Authors:  Nageswara R Madamanchi; Igor Tchivilev; Marschall Runge
Journal:  Curr Atheroscler Rep       Date:  2006-05       Impact factor: 5.113

5.  Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia.

Authors:  Alexander P Reiner; Jaana Hartiala; Tanja Zeller; Joshua C Bis; Josée Dupuis; Myriam Fornage; Jens Baumert; Marcus E Kleber; Philipp S Wild; Stephan Baldus; Suzette J Bielinski; João D Fontes; Thomas Illig; Brendan J Keating; Leslie A Lange; Francisco Ojeda; Martina Müller-Nurasyid; Thomas F Munzel; Bruce M Psaty; Kenneth Rice; Jerome I Rotter; Renate B Schnabel; W H Wilson Tang; Barbara Thorand; Jeanette Erdmann; David R Jacobs; James G Wilson; Wolfgang Koenig; Russell P Tracy; Stefan Blankenberg; Winfried März; Myron D Gross; Emelia J Benjamin; Stanley L Hazen; Hooman Allayee
Journal:  Hum Mol Genet       Date:  2013-04-24       Impact factor: 6.150

6.  Aberrant expression of myeloperoxidase in astrocytes promotes phospholipid oxidation and memory deficits in a mouse model of Alzheimer disease.

Authors:  Richard A Maki; Vladimir A Tyurin; Robert C Lyon; Ronald L Hamilton; Steven T DeKosky; Valerian E Kagan; Wanda F Reynolds
Journal:  J Biol Chem       Date:  2008-12-05       Impact factor: 5.157

7.  Elevated plasma free fatty acids increase cardiovascular risk by inducing plasma biomarkers of endothelial activation, myeloperoxidase and PAI-1 in healthy subjects.

Authors:  Manoj Mathew; Eric Tay; Kenneth Cusi
Journal:  Cardiovasc Diabetol       Date:  2010-02-16       Impact factor: 9.951

8.  Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.

Authors:  Lemin Zheng; Benedicta Nukuna; Marie-Luise Brennan; Mingjiang Sun; Marlene Goormastic; Megan Settle; Dave Schmitt; Xiaoming Fu; Leonor Thomson; Paul L Fox; Harry Ischiropoulos; Jonathan D Smith; Michael Kinter; Stanley L Hazen
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 9.  Oxidative risk for atherothrombotic cardiovascular disease.

Authors:  Jane A Leopold; Joseph Loscalzo
Journal:  Free Radic Biol Med       Date:  2009-09-12       Impact factor: 7.376

10.  Monocytes and neutrophils expressing myeloperoxidase occur in fibrous caps and thrombi in unstable coronary plaques.

Authors:  Fabio R Tavora; Mary Ripple; Ling Li; Allen P Burke
Journal:  BMC Cardiovasc Disord       Date:  2009-06-23       Impact factor: 2.298
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.